Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID)

BACKGROUND: Colchicine has been proposed as a potential therapy in coronavirus disease 2019 (COVID-19) due to their anti-inflammatory actions. METHODS: The COL-COVID study was a prospective, randomized, controlled and open-label clinical trial that compared colchicine added to standard treatment vs...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascual-Figal, Domingo A, Roura-Piloto, Aychel E, Moral-Escudero, Encarnación, Bernal, Enrique, Albendín-Iglesias, Helena, Pérez-Martínez, M Teresa, Noguera-Velasco, Jose Antonio, Cebreiros-López, Iria, Hernández-Vicente, Álvaro, Vázquez-Andrés, David, Sánchez-Pérez, Carmen, Khan, Amjad, Sánchez-Cabo, Fátima, García-Vázquez, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445096/
https://www.ncbi.nlm.nih.gov/pubmed/34539185
http://dx.doi.org/10.2147/IJGM.S329810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445096/
https://www.ncbi.nlm.nih.gov/pubmed/34539185
http://dx.doi.org/10.2147/IJGM.S329810

Ejemplares similares